4.4 Article

Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease

期刊

出版社

SPRINGER BASEL AG
DOI: 10.14283/jpad.2021.64

关键词

Alzheimer's disease; mild cognitive impairment; Cogstate Brief Battery; International Shopping List Test; cognitive decline

资金

  1. AstraZeneca Pharmaceuticals LP
  2. Australian Commonwealth Scientific Industrial and Research Organisation
  3. Edith Cowan University
  4. Mental Health Research Institute
  5. Alzheimer's Australia
  6. National Ageing Research Institute
  7. Austin Health
  8. Cogstate Ltd.
  9. Hollywood Private Hospital
  10. Sir Charles Gardner Hospital
  11. Biogen
  12. NHMRC [GNT1162645]

向作者/读者索取更多资源

Sensitive cognitive assessments can accurately detect and track cognitive decline in Alzheimer's disease. The use of frequent episodic memory assessments may aid in early detection of cognitive decline in individuals with mild cognitive impairment and mild Alzheimer's disease.
Sensitive cognitive assessments accurately detect and track cognitive decline in Alzheimer's disease. The Cogstate battery was used to measure cognitive change in cognitively normal participants and in individuals with mild cognitive impairment and mild Alzheimer's disease enrolled in the Australian Imaging, Biomarker and Lifestyle Rate of Change Substudy. Over 18 months, verbal episodic memory performance declined for mild cognitive impairment and mild Alzeheimer's disease groups when compared to cognitively normal participants. Frequent assessments of episodic memory may facilitate early detection of cognitive decline due to Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据